We can only indirectly measure inflammation and hypercoagulability through elevated blood markers for inflammation (like CRP, interleukin 6, ferritin) along with elevated D-Dimers, prolonged prothrombin time, and thrombocytopenia [26–28]. This evidence concerns the gene F2 and thrombophilia.